Compare stocks

Ambea AB is a company operating within the healthcare and social services industry, primarily offering care services in the Nordic region. The company provides elderly care, disabled care, and psychosocial support services, focusing on high-quality living and well-being for its users. Founded in 1996, Ambea is headquartered in Stockholm, Sweden, and operates through several brands, including Vardaga and Nytida, ensuring a broad service coverage across Sweden, Norway, and Denmark. The company is strategically positioned through its strong regional presence and an extensive network of facilities and professionals, enabling efficient service delivery and high standards of care.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.